in Pharma

Learning from Forecasting’s Past: How Previous Eras Will Shape the Pharma Forecaster of the Future

by Vanguard Software


Drugs representing more than $55 billion in sales will lose their patent exclusivity over the next four years, opening markets to rampant competition from low-cost generics producers. This evolution has already cast some additional uncertainty on drug developers and manufacturers, writes Art Cook, author of Forecasting for the Pharmaceutical Industry. To find their way, pharma companies will make great strides in their ability to model vast arrays of legal, regulatory and marketplace scenarios.

Vanguard Software Applications

Our collaborative, web-based forecasting applications unite roles, teams and departments in achieving the most accurate forecasts in the world – bar none.